organisation current research and strategies 2011 - 2012 - eortc

organisation current research and strategies 2011 - 2012 - eortc

Characteristics of the 36 ovarian cancer RCTs

Descriptive statistics of the EORTC QLQ-C30 and the QLQ-HCC18 and

Frontiers Hypnosis and cognitive behavioral therapy with online sessions to reduce fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: Rational and study protocol for a feasibility study

Cancers, Free Full-Text

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology

Frontiers Novel Combination Therapies for the Treatment of Bladder Cancer

KRAS mutation: from undruggable to druggable in cancer

organisation current research and strategies 2011 - 2012 - eortc

Mechanobiological Strategies to Augment Cancer Treatment

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

Frontiers Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation - The Lancet Oncology

organisation current research and strategies 2011 - 2012 - eortc